Drug Shortage Report for TEVA-BUDESONIDE
Report ID | 195478 |
Drug Identification Number | 02465957 |
Brand name | TEVA-BUDESONIDE |
Common or Proper name | TEVA-BUDESONIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.5MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION INHALATION |
Packaging size | 20 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | 2024-05-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v25 | 2024-03-28 | French | Compare |
v24 | 2024-03-28 | English | Compare |
v23 | 2024-03-21 | French | Compare |
v22 | 2024-03-21 | English | Compare |
v21 | 2024-03-14 | French | Compare |
v20 | 2024-03-14 | English | Compare |
v19 | 2024-01-25 | French | Compare |
v18 | 2024-01-25 | English | Compare |
v17 | 2024-01-18 | French | Compare |
v16 | 2024-01-18 | English | Compare |
v15 | 2023-11-16 | French | Compare |
v14 | 2023-11-16 | English | Compare |
v13 | 2023-10-26 | French | Compare |
v12 | 2023-10-26 | English | Compare |
v11 | 2023-10-05 | French | Compare |
v10 | 2023-10-05 | English | Compare |
v9 | 2023-07-27 | French | Compare |
v8 | 2023-07-27 | English | Compare |
v7 | 2023-07-19 | French | Compare |
v6 | 2023-07-19 | English | Compare |